2017
DOI: 10.1038/ncomms15071
|View full text |Cite
|
Sign up to set email alerts
|

Facile access to potent antiviral quinazoline heterocycles with fluorescence properties via merging metal-free domino reactions

Abstract: Most of the known approved drugs comprise functionalized heterocyclic compounds as subunits. Among them, non-fluorescent quinazolines with four different substitution patterns are found in a variety of clinically used pharmaceuticals, while 4,5,7,8-substituted quinazolines and those displaying their own specific fluorescence, favourable for cellular uptake visualization, have not been described so far. Here we report the development of a one-pot synthetic strategy to access these 4,5,7,8-substituted quinazolin… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
40
0

Year Published

2018
2018
2021
2021

Publication Types

Select...
10

Relationship

6
4

Authors

Journals

citations
Cited by 71 publications
(40 citation statements)
references
References 42 publications
0
40
0
Order By: Relevance
“…In the course of our ongoing research work on the design and synthesis of artemisinin‐derived hybrid compounds with antiviral, anticancer, and antimalarial activities, we also synthesized artemisinin‐containing product 9 i in 60 % yield (Figure ), starting from para ‐dihydroartemisinine‐substituted phenyl‐acetaldehyde. Biological investigations of the obtained hybrid 9 i in comparison to its parent compounds dihydroartemisinine and domino product 9 a are under way and will be reported elsewhere.…”
Section: Resultsmentioning
confidence: 99%
“…In the course of our ongoing research work on the design and synthesis of artemisinin‐derived hybrid compounds with antiviral, anticancer, and antimalarial activities, we also synthesized artemisinin‐containing product 9 i in 60 % yield (Figure ), starting from para ‐dihydroartemisinine‐substituted phenyl‐acetaldehyde. Biological investigations of the obtained hybrid 9 i in comparison to its parent compounds dihydroartemisinine and domino product 9 a are under way and will be reported elsewhere.…”
Section: Resultsmentioning
confidence: 99%
“…Examples include artemisinin-derived dimer diphenyl phosphate (838), a potent, selective HCMV inhibitor with irreversible activity [332,333] and trimeric artesunate derivative TF27 [326], which exhibits potent in vitro and in vivo activity in the MCMV model [329]. Hybridization of artemisinin-derivatives with bioactive molecules, such as quinazoline, has produced novel compounds with potent anti-HCMV activity significantly better than parental compounds and GCV [334][335][336][337].…”
Section: Artemisinin and Derivativesmentioning
confidence: 99%
“…LDH: lactate dehydrogenase release assay, 24 h, acute cytotoxicity; “n.d.”—not determined. [b] EC 50 values have been previously reported . [c] EC 50 values have been previously reported .…”
Section: Resultsmentioning
confidence: 99%